Therefore, conversion of the tumor suppressor C/EBPα into an oncogenic isoform can create preneoplastic foci where hepatocytes dedifferentiate into cancer cells, giving rise to liver cancer expressing high levels of mutated C/EBPα. This evidence concerns the gene CEBPA and cancer.